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Abstract
Targeting the highly conserved herpes DNA polymerase (DPOL) gene with PCR using panherpes
degenerate primers is a powerful tool to universally detect unknown herpesviruses. However,
vertebrate hosts are often infected with more than one herpesvirus in the same tissue, and pan-
herpes DPOL PCR often favors the amplification of one viral sequence at the expense of the others.
Here we present two different technical approaches that overcome this obstacle: (i) Pan-herpes
DPOL PCR is carried out in the presence of an oligonucleotide substituted with locked nucleic
acids (LNA).This suppresses the amplification of a specific herpesvirus DPOL sequence by a factor
of approximately 1000, thereby enabling the amplification of a second, different DPOL sequence.
(ii) The less conserved glycoprotein B (gB) gene is targeted with several sets of degenerate primers
that are restricted to gB genes of different herpesvirus subfamilies or genera. These techniques
enable the amplification of gB and DPOL sequences of multiple viruses from a single specimen. The
partial gB and DPOL sequences can be connected by long-distance PCR, producing final contiguous
sequences of approximately 3.5 kbp. Such sequences include parts of two genes and therefore
allow for a robust phylogenetic analysis. To illustrate this principle, six novel herpesviruses of the
genera  Rhadinovirus, Lymphocryptovirus and  Cytomegalovirus  were discovered in multi-infected
samples of non-human primates and phylogenetically characterized.
Background
PCR-based methods have been used for over a decade to
discover unknown herpesviruses. VanDevanter and cow-
orkers [1] were the first to design degenerate primers
against the highly conserved DPOL gene in order to detect
unknown herpesviruses by PCR. Since then, several varia-
tions of the original method were published, for example
PCR based on deoxyinosine substituted primers [2] or
consensus-degenerate hybrid oligonucleotide primers [3].
Despite of the tremendous efficiency of these methods in
detecting previously unknown viruses [4-8], they all have
a limitation: In specimens from a multi-infected individ-
ual, they usually amplify a viral sequence from only one
of the herpesviruses present. For example, pigs are
infected with three different lymphotropic herpesviruses
(PLHV-1, PLHV-2 and PLHV-3) with high prevalence, and
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a considerable percentage is double- or triple- infected
[9,10]. We easily detected PLHV-1 and PLHV-2 with pan-
herpes DPOL PCR [11] but we needed another 2 years and
a large collection of porcine blood and tissue samples to
find PLHV-3 with the same method in a small number of
PLHV-1- and PLHV-2-negative samples [9]. Retrospective
analysis of the sample collection with PLHV-3-specific
primers revealed that PLHV-3 was not less prevalent than
PLHV-1. However, less efficient amplification of PLHV-3
by pan-herpes DPOL PCR prevented its detection in dou-
ble- or triple-infected samples [unpublished data].
Another shortcoming limitation of this technique is, that
the amplified sequences are short (usually <0.5 kb).
Although this is beneficial for the sensitivity of the PCR,
short sequences are often not sufficient for the construc-
tion of phylogenetic trees revealing acceptable probabili-
ties for all clades.
Here we present a combination of two experimental
approaches to overcome these shortcomings: (i) Pan-her-
pes DPOL PCR was carried out in the presence of an addi-
tional oligonucleotide modified by the introduction of
locked nucleic acids (LNA). (ii) The less conserved glyco-
protein B (gB) gene was amplified with degenerate prim-
ers of limited detection capacity i.e. genus-specific
primers.
LNAs are ribonucleotides containing a methylene bridge
that connects the 2'-oxygen of the ribose with the 4'-car-
bon. The result is a locked 3'- endo conformation that
reduces the conformational flexibility of the ribose and
forces the conformational transition from the B-type to
the A-type [12]. The introduction of LNAs into DNA and
RNA improves the hybridization affinity and increases the
melting temperature by 1°-8°C/LNA nucleotide [13].
LNAs have been widely used for the control of gene
expression, in particular for therapeutic purposes
[Reviewed by: [14]]. A recent report described the use of
LNAs in cDNA-based real-time PCR in order to inhibit the
amplification of contaminating genomic DNA [15]. In the
present study, LNAs were used for the first time to exclu-
sively inhibit the amplification of known herpesvirus
sequences, thereby facilitating the amplification of addi-
tional unknown herpesvirus sequences from multi-
infected specimens.
The glycoprotein B (gB) gene is located immediately
upstream of the DPOL gene in beta- and gammaherpesvi-
ruses, and is less conserved than the DPOL gene. It only
allows for the design of more restricted degenerate prim-
ers i.e. gB sequences of a single herpesvirus subfamily or
genus can be amplified, while sequences of viruses
belonging to other genera remain excluded.
By combining these two experimental procedures, six
novel primate herpesviruses of the genera Rhadinovirus,
Lymphocryptovirus and Cytomegalovirus were discovered in
multi-infected specimens. To determine which gB and
which DPOL sequences originated from the same virus
genome, the putative gB/DPOL pairs were connected by
long-distance (LD) PCR. Final contiguous sequences of
approximately 3.5 kbp were compiled and used for robust
phylogenetic analysis.
Methods
Sample collection and DNA preparation
Blood and tissue samples from chimpanzees (Pan troglo-
dytes verus), deceased from various reasons, were collected
in the Taï National Park of Côte d'Ivoire. Samples of other
Old World primates, deceased in captivity, were collected
in the German Primate Centre (DPZ) and in the Zoologi-
cal Gardens of Berlin, Germany (Table 1). DNA was pre-
pared as described previously [16].
Pan-herpes PCR with specificity for the DNA polymerase 
gene
Pan-herpes PCR for amplification of 160 bp – 181 bp
(without primer binding sites) of the DPOL gene [2] was
carried out in a nested format with the degenerate and
deoxyinosine-containing (deg/dI) primers DFA, ILK and
KG1 in the first PCR round and TGV and IYG in the sec-
ond round (Figure 1) as described previously [6]. For LNA
Table 1: Origin of samples
Primate species Freeranging Individuals Organ Origin
Country Location
Pan troglodytes 
verus
Chimpanzee + 3 Spleen, muscle Côte d'Ivoire Taï National Park
Papio hamadryas Hamadryas 
baboon
- 5 Lung, spleen, liver, 
lymph node, heart
Germany German Primate 
Center
Macaca fascicularis Cynomolgus 
monkey
- 4 Blood, spleen, 
oesophagus
Germany German Primate 
Center
Colobus guereza Black-and-white 
colobus
- 4 Blood, liver, oral 
mucosa
Germany Zoological 
Gardens, BerlinVirology Journal 2007, 4:84 http://www.virologyj.com/content/4/1/84
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evaluation, the second round was carried out as real-time
PCR as described below.
Pan-herpes PCR in the presence of LNA
LNA-substituted oligonucleotides (LNA) (TIB MOLBIOL
GmbH, Berlin, Germany) were used to specifically inhibit
the amplification of primate lymphocryptovirus (LCV)
DPOL sequences, namely those of Pan troglodytes lym-
phocryptovirus 1 (PtroLCV-1), Gorilla gorilla lymphoc-
ryptovirus 1 (GgorLCV-1), Epstein-Barr virus (EBV),
Macaca fascicularis lymphocryptovirus 1 (MfasLCV-1),
Colobus guereza lymphocryptovirus 1 (CgueLCV-1),
Papio hamadryas lymphocryptovirus 2 (PhamLCV-2) [7]
and Callitrichine herpesvirus 3 (CalHV-3) [17]. An addi-
tional LNA was used to inhibit DPOL amplification of Pan
troglodytes rhadinovirus 1 (PtroRHV-1; this study). To
prevent the LNAs to function as PCR primers, an NH2-res-
idue was added at their 3'-end. All LNAs are listed in Table
2.
LNA-PtroLCV1, LNA-GgorLCV1, LNA-EBV, LNA-
PhamLCV2, LNA-CalHV3 and LNA-PtroRHV1 specifically
target the centre of the PtroLCV-1, EBV, PhamLCV-2,
CalHV-3 and PtroRHV-1 DPOL sequences, respectively,
which are amplified in the first round, and the 3'-end of
the DPOL amplimers which are amplified in the second
round of the pan-herpes DPOL PCR. With the exceptions
of LNA-CalHV3 and LNA-PtroRHV1, the LNAs overlap the
binding region of the inner anti-sense primer (IYG) by 2–
3 bp (Figures 1 and 2).
LNA-MfasLCV1 specifically targets the 5'-end of both the
MfasLCV-1 and the CgueLCV-1 sequence of the second
round of the pan-herpes DPOL PCR. It overlaps with the
binding region of the inner sense primer (TGV) by 2 bases
(Figures 1 and 2).
All LNAs were added to the PCR reaction mixes of both
the first and the second round of the pan-herpes DPOL
PCR in the same concentration as the PCR primers (1
µM).
Consensus-PCR with specificity for the glycoprotein B 
gene and for the major DNA binding protein gene of 
cytomegaloviruses
For the amplification of the gB gene, deg/dI primers were
used in a nested format (Table 3). The primers were
deduced from the gB genes of Equine herpesvirus 2
(primer set RH-gB), Epstein-Barr Virus (set LC-gB) and
Human Cytomegalovirus (set CM-gB) and used for ampli-
fication of members of the genera Rhadinovirus, Lymphoc-
ryptovirus  and  Cytomegalovirus, respectively. They were
degenerated and substituted with deoxyinosine at their 3'-
end. Their binding region is depicted in Figure 1. PCR was
carried out as described for the DPOL gene, with an
annealing temperature of 45°C.
For the major DNA binding protein (MDBP) gene ampli-
fication of members of the genus Cytomegalovirus, nested
consensus PCR was carried out with deg/dI primers,
which were deduced from the MDBP gene of Cercopithe-
cine herpesvirus 8 (CeHV-8) (Table 3). The PCR was car-
ried out as described for the DPOL gene, with an
annealing temperature of 46°C.
PCR under less stringent conditions
Samples without amplification product in the panherpes
DPOL PCR and in all gB PCRs were reanalysed under
more relaxed conditions i.e. the ramp time between the
annealing step and the extension step was prolonged 50-
fold. In addition, the polymerase was only partially acti-
vated before cycling (2 min at 90°C), and the number of
cycles was increased from 45 to 50.
LNA-based and bigenic amplification of beta- and gammaher- pesviruses Figure 1
LNA-based and bigenic amplification of beta- and 
gammaherpesviruses. Schematic diagram of the analysis 
strategy. (A, right) Initially, panherpes nested PCR with deg/
dI primers (black triangles) is performed for amplification of 
DPOL sequences. In the first round, primers for amplification 
of 710 bp and 480 bp are used simultaneously, either in the 
absence or presence of LNA. The binding regions of the LNA 
are present in the amplified sequences of both the first and 
the second PCR round, and represented by short thick lines. 
The targeted viruses are indicated. (A, left) The binding 
regions of genus-specific deg/dI gB-primers are indicated by 
black triangles. Amplimers of the first and the second PCR 
round are 320 bp and 250 bp, respectively. (B) After both gB 
and DPOL sequences were determined, long-distance nested 
PCR (dashed lines) was performed with specific primers 
(open triangles) binding to gB (sense) and DPOL (antisense). 
(C) A final contiguous sequence of approximately 3.5 kbp 
was obtained (solid line).
Degenerate PCR primer set,
specific for a herpesvirus genus
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Table 2: LNA sequences
LNA (Name) LNA (Sequence)$ Target DPOL 
sequence
Tm of DNA-
oligomer (°C)#
Tm of LNA-oligomer 
(°C)#
∆Tm (°C)
LNA-PtroLCV1 5'- 
+a+tg+a+cg+cg+t+a
g+c+c+g --NH2
P t r o L C V - 1 5 58 22 7
LNA-GgorLCV1 5'- 
+at+a+acgcgt+a+gcc
+g+accc --NH2
G g o r L C V - 15 17 72 6
LNA-EBV 5'- 
g+atg+act+cgaag+ct
gg+ccct --NH2
EBV 63 72 9
LNA-MfasLCV1 5'- 
g+tggcc+a+acggcc+t
c --NH2
MfasLCV-1 and 
Cgue LCV-1
60 69 9
LNA-PhamLCV2 5'- 
asg+ac+acgc+a+accg
g --NH2
PhamLCV-2 59 67 8
LNA-CalHV3 5'- 
ac+tcgcag+ta+tacca
+tccg --NH2
C a l H V - 3 5 46 91 4
LNA-PtroRHV1 5'- 
+a+acc+t+tg+a+a+t
c+tggcg+tc -- NH2
P t r o R H V - 15 67 21 5
$All bases in LNA conformation are preceeded by +
# Tm calculated with the Exiqon Tm prediction algorithm.
Alignment of LNA-substituted oligonucleotides Figure 2
Alignment of LNA-substituted oligonucleotides. The LNAs, used in this study for specific inhibition of LCV amplifica-
tion, were multiply aligned with their target sequences. The LNA-substituted bases are highlighted by circles. Identical nucle-
otides are boxed. For comparison, an LCV consensus sequence is shown, which was derived from all published LCV DPOL 
sequences. The bases 1 and 175 are the first and the last base of the sequence, which is amplified from LCV with pan-herpes 
DPOL primers (Bases 154668 and 154494 of the EBV B 95–8 genome [Acc. V01555], respectively). Only the 5'- and the 3'-
ends are shown, the central part of the consensus sequence is represented by the dotted line. The 3'- ends of the binding 
regions of the inner consensus primers TGV (sense) and IYG (antisense) are indicated.
EBV
EBV LNA
PtroLCV1
PtroLCV1 LNA
GgorLCV1
GgorLCV1 LNA
PhamLCV2
PhamLCV2 LNA
CalHV3
CalHV3 LNA
Consensus LCV
CCGAGGGC C A GCTT CGA GTCATC
AGGGC C A GCTT CGA GTCATC
CCGAGGGC CGGCTA CGC GTCATC
CGGCTA CGC GTCAT
CCGAGGGT CGGCTA CGC GTT ATC
GGGT CGGCTA CGC GTT AT
CCGC GGGC CGGT T G CGT GTCATC
C CGGT T G CGT GTCAT
C G GAT GGTATACTG CGA GTCATT
C G GAT GGTATACTG CGA GT
VVG V-GGB---VT DMG - GTH ATY
Consensus LCV
CgueLCV1
MfasLCV1
MfasLCV1 LNA
GTV GCMMA Y GGYYT S
GTGGCCAACGGCCTC
GTGGCCAACGGCCTC
GTGGCCAACGGCCTC
Inner anti-sense primer IYG
Inner sense primer TGV
1
175
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Long-distance PCR
LD-PCR was performed with the TaKaRa-Ex PCR system
(Takara Bio Inc., Japan) or the Long-template PCR system
(Roche, Switzerland) according to the manufacturer's
instructions, and amplimers were obtained by nested
PCR. For the second round, a one µl aliquot of the first
round was used as template.
Specific amplification of DPOL sequences from 
lymphocryptoviruses
From EBV, PtroLCV-1, GgorLCV-1 and CalHV-3, segments
of the respective DPOL genes (approximately 1 kbp) were
amplified (primers not listed). The amplimers span the
entire binding region of the deg/dI pan-herpes DPOL
primers, and were used in dilution series to test the LNA
efficiency in the pan-herpes DPOL PCR.
Real-time PCR
For the quantitative evaluation of LNA efficiency, the sec-
ond round of pan-herpes DPOL PCR was performed as
real-time PCR. The PCR mix was made up to a volume of
25 µl containing 1.5 µl of the first round reaction product,
1 × PCR buffer, 2 mM MgCl2, 0.2 mM (each) of dATP,
dCTP, dGTP and dTTP (Fermentas, St. Leon-Rot, Ger-
many, respectively), 2 U of AmpliTaq Gold DNA polymer-
ase (Applied Biosystems, Foster City, CA, USA), 1 µM
(each) of the forward and reverse primers, 1.0 µM SYBR
Green I and 1.0 µM ROX as a passive reference. LNAs were
added to the PCR reaction mix in a concentration of 1 µM.
The reactions were carried out in 8-tube-strips (ABgene,
Epsom-Surrey, UK) using an ABI Prism 7500 Sequence
Detector (Applied Biosystems, Foster City, CA, USA).
Sequence analysis and phylogenetic tree construction
PCR product purification, direct sequencing with dye ter-
minator chemistry as well as nucleotide and amino acid
sequence analysis were performed as described [18].
Sequence files were assembled with the Seqman module
of the Lasergene software (GATC, Konstanz, Germany).
BLAST searches were performed using the NCBI database.
ORF prediction and calculation of identity values were
performed with the program MacVector (Version 8.0).
Multiple sequence alignments were performed with the
clustalW module of MacVector. For phylogenetic tree con-
struction, a multiple alignment of concatenated 1100
amino acids (aa) was analysed with the neighbor-joining
method (MacVector). In addition, the alignment was ana-
lysed with the program Tree-Puzzle (Version 5.0).
Tentative nomenclature of novel herpesviruses
For the purpose of this study, the novel viruses were
named trinomially: The first 2 words designate the name
of the host species, while the third word designates the
tentative assignment of the novel virus to a herpesvirus
genus within the Herpesviridae. The numbering was done
according to the chronological order of discovery. Exam-
ple: Macaca fascicularis rhadinovirus 1.
Abbreviations use the first letter of the generic host name
and the first three letters of the specific host name, fol-
lowed by the abbreviation of the viral genus. Example:
Macaca fascicularis rhadinovirus (RHV) 1, MfasRHV-1.
Nucleotide sequence accession numbers
Accession numbers for sequences of published viruses
are:Betaherpesvirinae: HCMV (cg, NC 001347); HHV-6A
(cg, NC 001664); HHV-7 (cg, NC 001716); PtroCMV-1
(cg, NC 003521). Gammaherpesvirinae: CalHV-3 (cg, NC
004367); CeHV-15 = Rhesus LCV (cg, X00784); EBV (cg,
NC 007605); PtroLCV-1 (AF534226); MfasLCV-1
(AF534221); CgueLCV-1 (AF534219); HHV-8 (cg, NC
003409); HVS = SaHV-2 (cg, NC 001350); RRV strain
17577 (cg, AF083501); RRV strain 26–95 (cg, AF210726).
The novel sequences reported here were deposited in Gen-
Bank under the following accession numbers: PtroRHV-1,
acc. AY138585; PtroRHV-2, acc. EU085378; MfasRHV-1,
acc. AY138583; MfasRHV-2, acc. EU085377; PhamLCV-2,
acc. AF534229; PhamLCV-3, acc. EU11846; CgueCMV-
1.1, acc. AY129397; CgueCMV-1.2, acc. EU11847.
Results
LNA-substituted oligonucleotides specifically inhibit the 
amplification of DPOL sequences in the pan-herpes DPOL 
PCR
Approximately 1 kbp of the PtroLCV-1, the GgorLCV-1,
the EBV and the CalHV-3 DPOL gene were amplified with
specific primers (not listed). These PCR fragments span
the complete DPOL region targeted by pan-herpes con-
sensus PCR (Figure 1). Serial ten-fold dilutions of these
fragments, covering a range of 107 to 10-1 copy numbers,
were used as templates in the pan-herpes DPOL PCR,
either in the presence or absence of perfectly matching
LNAs.
The amplification of PtroLCV-1 DPOL was severely
impaired by LNA-PtroLCV1. In the presence of this LNA,
a minimum of 1000 copies was needed to obtain an
amplimer visible after gel-electrophoretic analysis (not
shown). In the absence of LNA-PtroLCV1, 1–10 copies of
PtroLCV-1 were still amplifiable. Similar results were
achieved by repeating the second PCR round in the pres-
ence of SYBR green I in a real-time set-up. In the presence
of LNA-PtroLCV1, the CT-values rose by 11–12 cycles (Fig-
ure 3a). From this data it was concluded that LNA-
PtroLCV1 inhibited the amplification of PtroLCV-1 DPOL
by a factor of approximately 1000.
A similar inhibition efficiency was seen when the
GgorLCV-1 DPOL template was amplified in the presenceVirology Journal 2007, 4:84 http://www.virologyj.com/content/4/1/84
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of LNA-GgorLCV1 (factor approximately 1.000). The EBV
DPOL template was even more effectively inhibited in the
presence of LNA-EBV (factor >10.000) (data not shown).
Various LNA concentrations were tested for their inhibi-
tion efficiency. Concentrations of 4 µM, 2 µM, 1 µM and
0.5 µM of LNA-PtroLCV1 inhibited the amplification of
PtroLCV-1 DPOL to a similar degree. A concentration of
0.25 mM resulted in a decreased inhibition (not shown).
For the remainder of the experiments presented here a 1
µM of LNA was routinely used.
We next tested, whether LNAs exert their effect in a
sequence-specific manner. For this purpose, EBV DPOL
was amplified in the presence of the LNA-PtroLCV1 that
contains 3 mismatches within the LNA binding region.
Two of the mismatches were LNA-substituted (Figure 2).
In the presence or absence of the LNA, a similar amount
of amplimer was obtained in real-time PCR. Thus, the
amplification of EBV DPOL was not inhibited by the LNA-
PtroLCV1 (not shown). Conversely, the PtroLCV-1 tem-
plate was tested with LNA-EBV, which also exhibits 3 mis-
matches within the LNA binding region. However, no
mismatch was LNA-substituted (Figure 2). Using 103 tem-
plate molecules, a slight inhibition (factor of <10) was
observed. Higher template concentrations were not
affected by the LNA-EBV as revealed by real-time PCR
(Figure 3b).
Finally, we tested the impact of LNAs, which exhibit only
one or two mismatches to a certain DPOL sequence in
their binding region. LNAGgorLCV1 exhibits two mis-
matches to the PtroLCV-1 DPOL, and both were LNA-sub-
stituted (Figure 2). With LNA-GgorLCV1, the inhibitory
effect on amplification of the PtroLCV-1 DPOL sequence
was 10-fold lower than on the exactly matching GgorLCV-
1 DPOL sequence. In the case of the LNA-PtroLCV1, the
one mismatch to the GgorLCV-1 sequence was not LNA-
substituted (Figure 2), and LNA-PtroLCV1 inhibited the
amplification of GgorLCV-1 DPOL to the same extent as
the amplification of the perfectly matching PtroLCV-1
template. Thus LNA-PtroLCV1 did not discriminate
between these templates (data not shown).
Selective amplification of herpesvirus DPOL templates 
from template mixtures using pan-herpes PCR and LNA-
substituted oligonucleotides
Three mixtures of the 1 kbp templates of the GgorLCV-1,
EBV and CalHV-3 DPOL genes were prepared. In each of
these, one template was present in a copy number repre-
senting its individual detection limit in the pan-herpes
PCR. The other two templates were present in 10-fold
excess over their individual detection limit. Pan-herpes
PCR was set up in the presence of two LNAs targeting the
two over-represented HV. In each LNA-supplemented
PCR assay, the amplification of the two over-represented
HV was inhibited and the single under-represented HV
was amplified as revealed by sequencing (Table 4, assays
A to C). The experiment was repeated, but with the two
over-represented HV present in 100-fold excess. In the
assays D and E, listed in Table 4, the under-represented
GgorLCV-1 DPOL and EBV DPOL were selectively ampli-
Table 3: Primers for amplification of the glycoprotein B gene
Primer set Name of primer PCR round Sequence 5'- 3' Product length $ (bp)
RH-gB 2759s 1 CCTCCCAGGTTCARTWYGCMTAYGA 700
2762as CCGTTGAGGTTCTGAGTGTARTARTTRTAYTC
2760s 2 AAGATCAACCCCAC(N/I#)AG(N/I)GT(N/I)ATG 500
2761as GTGTAGTAGTTGTACTCCCTRAACAT(N/I)GTYTC
LC-gB 2753s 1 CCATCCAGATCCARTWYGC(N/I)TAYGA 650
2756as GATGTTCTGCGCCTRRWARTTRTA
2754s 2 TGGCTGCCAAGCG(N/I)(N/I)T(N/I)GG(N/I)GA 460
2755as GATGTTCTGCGCCTGRWARTTRTAYTC
CM-gB 2743s 1 CGCAAATCGCAGA(N/I)KC(N/I)TGGTG 330
2746as TGGTTGCCCAACAG(N/I)ATYTCRTT
2744s 2 TTCAAGGAACTCAGYAARAT(N/I)AAYCC 250
2745as CGTTGTCCTC(N/I)CC(N/I)ARYTG(N/I)CC
CM-MDBP 3730s 1 TGTGGCTTCTCATGCTTvCA[n/i]TT[n/i]TG 560
3730as GTTGAGGCTCCG[n/i]TCsAC[n/i]CC
3731s 2 CTATCTCGAGCATCG[n/i]TTyCAyAAC 350
3731as AAAAGTACCCAATCTG[n/i]CCrAAsTG
# I = Inosine
$ approximate valuesVirology Journal 2007, 4:84 http://www.virologyj.com/content/4/1/84
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fied, respectively. However, when CalHV-3 was under-
represented, the 100-fold over-represented GgorLCV-1
DPOL was detected instead (Table 4, assay F).
To further investigate the versatility of the LNA-supple-
mented panherpes PCR, four identical mixtures of four
LCV templates were prepared. This time, template concen-
trations were chosen at which amplification was only par-
tially inhibited by the LNA. Three LNAs were added to
each of the four PCR reactions in four different combina-
tions. From each mixture the expected sequence was
amplified i.e. that sequence against which no correspond-
ing LNA had been added (data not shown). It was con-
cluded that at least four unknown herpesviruses might be
selectively amplified from multi-infected samples using a
panel of LNAs.
Discovery of rhadinoviruses in lymphocryptovirus-positive 
samples of chimpanzees
The LNAs, which were successfully used in dissecting arti-
ficial LCV template mixtures, were now used for the anal-
ysis of herpesvirus-positive blood and tissue samples of
primates. Samples of two chimpanzees ("Noah" and
"Leo";  Pan troglodytes verus), which lived in the Taï
National Park of Côte d'Ivoire and died from anthrax dis-
ease [19], were analysed with pan-herpes DPOL PCR
resulting in the detection of PtroLCV-1 [7]. To unravel the
simultaneous presence of other herpesviruses, the pan-
herpes DPOL PCR was carried out in the presence of LNA-
PtroLCV1, using spleen samples of Noah and Leo. As a
control, the PCR was carried out without LNA. While in
the control reaction PtroLCV-1 DPOL was amplified, the
presence of the LNA resulted in the amplification of a
novel RHV DPOL sequence. The virus, from which this
sequence originated, was tentatively named PtroRHV-1.
To amplify a gB sequence of PtroRHV-1, the gB primer set
RH-gB was then applied to several samples from Noah,
Leo and chimpanzees of the same group. In a sample of
the chimpanzee "Gargantuan", a RHV gB sequence was
detected. It could be connected to the PtroRHV-1 DPOL
sequence by LD-PCR, and therefore originated from
PtroRHV-1. A 3.4 kbp sequence was finally compiled
spanning the 3'-end of the gB gene (approximately 1 kb)
and the 5'-end of the DPOL gene (approximately 2.2 kb)
of PtroRHV-1 (Figure 1).
In the spleen samples of Noah and Leo, a different RHV
gB sequence was detected, as indicated by an identity per-
centage of only 70% to the PtroRHV-1 gB sequence. The
virus, from which this gB sequence originated, was tenta-
tively named PtroRHV-2.
To amplify the DPOL sequence of PtroRHV-2, two aliq-
uots of Leo's spleen, originating from different regions
within the organ, were subjected to pan-herpes DPOL
PCR. This time two LNAs were used (LNA-PtroLCV1 and
LNA-PtroRHV1; Table 2 and Figure 1) to simultaneously
inhibit the amplification of PtroLCV-1 and PtroRHV-1
DPOL and thus to be able to detect PtroRHV-2 DPOL. In
aliquot 1 of Leo's spleen, PtroLCV-1 was detected in the
absence of the LNAs. By including LNA-PtroLCV1,
PtroRHV-1 was detected. Using both LNAs, nothing was
detected. Therefore, the sample did apparently not con-
tain PtroRHV-2 in a copy number sufficient for pan-her-
pes PCR (Figure 4). However, the dual-inhibition
approach proved successful with the second spleen aliq-
uot. Using both LNAs, a second RHV DPOL sequence was
discovered (Figure 4). It revealed a percentage of identity
to PtroRHV-1 DPOL of 52%. This DPOL sequence could
be connected to the PtroRHV-2 gB sequence by LD-PCR,
Real-time PCR of PtroLCV-1 DPOL in the presence or  absence of LNA Figure 3
Real-time PCR of PtroLCV-1 DPOL in the presence 
or absence of LNA. Amplification curves are shown for 
pan-herpes DPOL PCR with a PtroLCV-1 DPOL amplimer (1 
kbp) as template (103 – 106 copy numbers). Real-time PCR 
was carried out in the presence or absence of (A) LNA-
PtroLCV1 or (B) LNA-EBV.
A
B
106 105 103 104
106 105 103 104
Copy number of
PtroLCV-1 template
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PtroLCV1-LNA
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and therefore originated from PtroRHV-2. A 3.4 kbp
sequence of PtroRHV-2 was finally compiled (Figure 1).
In a pair-wise nucleic acid sequence comparison, the 3.4
kbp sequence of PtroRHV-1 was found to be 99% identi-
cal in its 3'-terminus to a 1 kbp DPOL sequence detected
in a captive Pan troglodytes troglodytes [20]. The 3.4 kbp
sequence of PtroRHV-2 was 98% identical in its 3'-termi-
nus to a 1.1 16 kbp DPOL sequence detected in three wild-
caught Pan troglodytes troglodytes, one from Gabon and two
from Cameroon [21]. No close matches were found in
Genbank for the 5'-parts (2.4 kbp) of the PtroRHV-1 and
PtroRHV-2 sequences, spanning a part of the DPOL and
the gB gene. Since both originated from Pan troglodytes
verus (Côte d'Ivoire), they were regarded as originating
from hitherto unknown P. tr. verus RHV, closely related to
P. tr. troglodytes RHV.
Discovery of rhadinoviruses in LCV-positive samples of 
cynomolgus monkeys
Blood and organ samples of 18 cynomolgus monkeys
(Macaca fascicularis) from the colony of the German Pri-
mate Centre were analysed with panherpes DPOL PCR. In
21 out of 35 samples, amplimers of Macaca fascicularis
lymphocryptovirus 1 (MfasLCV-1) [7] were obtained
(data not shown). In one blood sample, a rhadinovirus
DPOL sequence was found and the virus tentatively
named Macaca fascicularis rhadinovirus 1 (MfasRHV-1).
Re-inspection of the individuals with the gB primer set
RH-gB revealed two RHV gB sequences (RHV1-gB and
RHV2-gB). They had only 72% nucleotide sequence iden-
tity to each other. LD-PCR revealed that the RHV1-gB
sequence originated from the same virus genome as the
MfasRHV-1 DPOL sequence. A final gB to DPOL sequence
(3.4 kbp) of MfasRHV-1 was compiled.
The virus from which the RHV2-gB sequence originated
was tentatively named MfasRHV-2. To amplify a DPOL
sequence of MfasRHV-2, the panherpes DPOL PCR was
carried out in the presence of LNA-MfasLCV1. As a con-
trol, the PCR was carried out without LNA. While
MfasLCV-1 DPOL was amplified in the control reaction,
the presence of the LNA resulted in the amplification of a
second RHV DPOL sequence. This could be connected to
the MfasRHV-2 gB sequence with LD-PCR, resulting in a
final MfasRHV-2 gB to DPOL sequence of 3.4 kbp.
The MfasRHV-1 DPOL sequence was 95% identical to that
of the retroperitoneal fibromatosis virus, a RHV detected
in  Macaca mulatta [22]. The 3'-end of the MfasRHV-2
sequence was 98% identical to a RHV sequence (475 bp),
which had been detected in the USA in M. fascicularis orig-
inating from Indonesia (Genbank accession AF159032)
[23]. Pairwise comparison of the complete gB to DPOL
sequence of MfasRHV-1 with the corresponding
sequences of (i) MfasRHV-2, (ii) rhesus monkey rhadino-
virus and (iii) Human herpesvirus 8 revealed identities of
65%, 67% and 64%, respectively.
Discovery of a third lymphocryptovirus species in an LCV-
positive sample of a baboon
Two LCV of baboons (Papio hamadryas) are presently
known, Papio hamadryas lymphocryptovirus 1 (Pham-
LCV-1 = Herpesvirus papio = Cercopithecine herpesvirus 12)
[24] and Papio hamadryas lymphocryptovirus 2 (Pham-
LCV-2) [7]. While several genomic regions of PhamLCV-1
had been already determined, including the complete gB
gene [25], only a short partial DPOL sequence of Pham-
LCV-2 had been described [7]. Therefore, we inspected
five PhamLCV-2-positive P. hamadryas with the LC-gB
primer set. Two different gB sequences were detected.
The first could be connected to the PhamLCV-2 DPOL
sequence by LD-PCR, and a final PhamLCV-2 sequence of
3.2 kbp was obtained. The second gB sequence differed
slightly from the corresponding gB sequences of Pham-
LCV-1 and PhamLCV-2 (90% and 95% identity, respec-
tively). The virus from which this gB sequence originated
was tentatively named PhamLCV-3.
To amplify a DPOL sequence of PhamLCV-3, the panher-
pes DPOL PCR was performed with and without LNA-
PhamLCV2. In the control reaction PhamLCV-2 DPOL
was amplified, while the presence of the LNA resulted in
the amplification of a different LCV DPOL sequence (85%
identity). This putative PhamLCV-3 sequence could be
Pan-herpes DPOL PCR of chimpanzee samples in the pres- ence or absence of LNA Figure 4
Pan-herpes DPOL PCR of chimpanzee samples in the 
presence or absence of LNA. Pan-herpes DPOL PCR was 
carried out on aliquots of chimpanzee Leo's spleen (#2290; 
#4123) in the absence (-) or presence (+) of LNA-PtroLCV1 
and/or LNA-PtroRHV1. The electropherogram is shown. 
Below, the amplified DPOL sequences are indicated. Marker: 
100 bpladder (lanes 1 and 8).
M 1 2345 M
LNA-PtroLCV1 +
6
+ -
+
LCV-1
RHV-1
-
-
RHV-1
LCV-1
RHV-2
Sample number #2290 #4123
200 bp ￿
-
- LNA-PtroRHV1
-
++
+
300 bp ￿
400 bp ￿
500 bp ￿
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connected with the PhamLCV-3 gB sequence by LD-PCR,
resulting in a final PhamLCV-3 gB to DPOL sequence of
3.3 kbp.
An alignment of the novel PhamLCV-3 sequence with
LNA-PhamLCV2 revealed three mismatches. In addition,
one of the mismatching bases within the LNA-PhamLCV2
was LNA-substituted. These features most probably pre-
vented the targeting of PhamLCV-3 DPOL by LNA-
PhamLCV2.
The three LCV of P. hamadryas were compared on the basis
of gB sequences (a longer DPOL sequence was not availa-
ble for PhamLCV-1). Identity percentages of 89% (LCV-3
versus LCV-1) and 93% (LCV-3 versus LCV-2) were
obtained.
Discovery of cytomegaloviruses in LCV-positive samples of 
a black-and-white colobus
Blood, spleen, brain, kidney, bone marrow, stomach and
mucosa of the mouth of a black-and-white colobus (Colo-
bus guereza) from the Berlin zoological gardens, which
died of a disease of unclear etiology, were analysed with
pan-herpes DPOL PCR. In 6/7 samples, the lymphocryp-
tovirus CgueLCV-1 [7] was found. In the kidney, a novel
cytomegalovirus was discovered and tentatively named
Colobus guereza cytomegalovirus 1 (CgueCMV-1).
Inspection of all samples with the gB primer set CM-gB
revealed two distinct gB sequences. One was found in the
kidney and brain and the other in liver and mucosa
(CMV-1 and CMV-2, respectively). They had a nucleotide
sequence identity of 82%. With LD-PCR, the CMV-1 gB
sequence and the CgueCMV-1 DPOL sequence could be
connected (Figure 5A).
The virus, from which the CMV-2 gB sequence was
derived, was tentatively named CgueCMV-2. To amplify
the missing DPOL sequence of CgueCMV-2, the
CgueCMV-2-positive samples were subjected to the pan-
herpes DPOL PCR in the presence of the LNA-MfasLCV1
(Table 3 and Figure 2). In the control reaction without
LNA CgueLCV-1 DPOL was amplified, while the presence
of the LNA-MfasLCV1 surprisingly resulted in the amplifi-
cation of CgueCMV-1 DPOL with 100% identity. Because
no other CMV sequence was found, we speculated that
Table 4: Amplification of an under-represented LCV species in the presence of two over-represented, closely related LCV species
Viral 
templates 
added to the 
PCR reaction
Copy number 
of added 
template
Pan-herpes 
PCR 
detection 
limit 
(template 
copy number)
Ratio 
between 
added 
template 
concentration 
and the 
detection 
limit
LNA added Expected 
virus 
detection
Detected 
virus
A 1 EBV 10.000 10.000 1 -
2 GgorLCV1 100 10 10 GgorLCV1 EBV EBV
3 CalHV3 10 1 10 CalHV3
B 1 EBV 100.000 10.000 10 EBV
2 GgorLCV1 10 10 1 - GgorLCV1 GgorLCV1
3 CalHV3 10 1 10 CalHV3
C 1 EBV 100.000 10.000 10 EBV
2 GgorLCV1 100 10 10 GgorLCV1 CalHV3 CalHV3
3 C a l H V 3 111-
D 1 EBV 10.000 10.000 1 -
2 GgorLCV1 1000 10 100 GgorLCV1 EBV EBV
3 CalHV3 100 1 100 CalHV3
E 1 EBV 1000.000 10.000 100 EBV
2 GgorLCV1 10 10 1 - GgorLCV1 GgorLCV1
3 CalHV3 100 1 100 CalHV3
F 1 EBV 1000.000 1.000 100 EBV
2 GgorLCV1 1000 10 100 GgorLCV1 CalHV3 GgorLCV1
3 C a l H V 3 111-Virology Journal 2007, 4:84 http://www.virologyj.com/content/4/1/84
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Amplification of an 8 kbp locus of CgueCMV-1.1 and CgueCMV-1.2 Figure 5
Amplification of an 8 kbp locus of CgueCMV-1.1 and CgueCMV-1.2. At the top of the figure, the betaherpesvirus 
ORFs UL57 (MDBP) to UL54 (DPOL) are depicted by open arrows. (A) The partial sequences of the ORFs UL57, UL55 and 
UL54, obtained through PCR with deg/dI primers, are depicted by thin solid lines, and the type of gB sequence (gB1 or gB2) is 
indicated. LD amplimers are depicted by dashed lines. The solid line represents the final 8 kbp contiguous sequences of 
CgueCMV-1.1 and CgueCMV-1.2. (B) Pairwise alignments of the UL56 and gB proteins and the partial DPOL proteins of 
CgueCMV-1.1 and CgueCMV-1.2 are shown. Dots represent identical amino acids, dashes indicate regions of non-colinearity.
CgueCMV1.1 MTQIWFLVACASLLTVSNTASTTSNVSSTPTASSSSSDRTPASSTAADNGTTAPFIANTTVRTNEVVSLDKARFPYRVCSMSQGTDFLRFDNNIQCEAFK 100
CgueCMV1.2 ..K.....V.........I.........A...V...N---.TPTSTS......GLVP...L.....LD..RSKY.......A........E......... 97
CgueCMV1.1 PTKEDFDEGIMLVYKRDIRAYTFKVHVYQKVVTQRQSYSYIVINYMLGQTVEHLPVPMWEVHYINKLNRCYNSILRVMGDKTYYSYHKDSFVNETMVLVP 200
CgueCMV1.2 ................N..............L.........ST.....K...E..........V.RI......V..F.N.EP.....M.T......L..Q 197
CgueCMV1.1 DDFSNTHSSRFVTVKQLWHKPGSTWLYTTSTNVNCMVTVTTARSRYPYNFFVTSAGEVVDISPFYNGSNDKHFGENRDKFHLKRNYTMVQYYGADNAPES 300
CgueCMV1.2 ..Y.....T......K....A...........I....................AS.D..........T.G.....TK....VFN..S..E...RE.V.QV 297
CgueCMV1.1 AHPLVAFFERADSLMSWDIVDESNNTCQYALWEVSERTIRSEAEHTYHFTSASMTATFLSKKETVNISDPALECVREEVEARLEKLFNTTYNETYAKSGN 400
CgueCMV1.2 N..M...............L..A.....F....T..........D......SK.S....T..I...E.....T.IKD.ASEQ.Q.IY.Q...S..VQ... 397
CgueCMV1.1 VTVYETTGGLIVFWLPVKEKSLLEMERLTKNSTNAT--VRSKRSLDNG--NSTEVLHSVVYAQLQFTYDTLRNYINRALRQIADAWCRDQKRTAEVLKEL 496
CgueCMV1.2 MSI..............Q.RAIW..KQ.NDGRQ.V.NSS.HR..T.SSLL.N....QN.............................K.....L...... 497
CgueCMV1.1 SKINPSAMLSAIYDKPIAARHIGDVISLAKCVEVDQDSVQVVRDMHVKGQNDVCYSRPVVLFRFKNSSHVHYGQLGEHNEILLGRHRTETCEVPSLKIFI 596
CgueCMV1.2 ..................................E.T....I......D.TG..........T.......Q......Y..............T....... 597
CgueCMV1.1 AGNTSYEYVDYLFKGEIPLESIPTIDTLIALDIDPLENTDFKALELYSQDELRASNVFDLEEIMREFNSYRQRIVFMEDKVFDTVPSYLRGLDDLMSGLG 696
CgueCMV1.2 ...........VY.R..S.D.......M.S...................E...S.......D.............T..G.......G............. 697
CgueCMV1.1 AAGKALGVAIGAVGGAVASIMDGIAGFLKNPFGSFTVVLFLLAVLGVIYLIYMRQRRMYESPLQHLFPYVVPGAVHKETPPPPSYEESVYASIKEKKSAS 796
CgueCMV1.2 ................................................................................................-... 796
CgueCMV1.1 PTREFSVEDAYQMLLALQRLDQEKRNKSEDDVESPFPADGADRPGLLDRLRYRNRGYKRLQNEYEV 862
CgueCMV1.2 .................................................................. 862
CgueCMV1.1 MFFNPYLSGGRKPSAPVAKRPVDKTFLEIVPRGAMYDGQSGLIKHKTGRGPLMFYREIKHMLDNDMAWPCPLPPPPPSIETFARRISGPLKFHTYDQVDG 100
CgueCMV1.2 ............................................................T....................................... 100
CgueCMV1.1 VLAHDTSEAVSPRYRPHIIPSGNVLRFFGATEQGYTICVNVFGQRSYFYCQYPDGDRLRDLIASVSELVSEPRMAYALSIVQVTKMSIYGYGTQPVPDLY 200
CgueCMV1.2 ..................................................................D................................. 200
CgueCMV1.1 RVSISNWSMAKKIGEHLLDQGIPVFEVRVDPLTRLVIDKKMTTFGWCCVNRYDWRGYGKKSSTCDFEVDCDVADLIALADDTSWPVYRCLSFDIECMSGC 300
CgueCMV1.2 .......T............................................E............................................... 300
CgueCMV1.1 GGFPVAEQVDDIVIQISCVCYETGGTGREGEEGSAVFGTSGLHLFTIGGCGQVGTADVYEFPSEYEMLLGFLIFFKRYAPCFVTGYNINSFDFKYILTRL 400
CgueCMV1.2 .................................................................................................... 400
CgueCMV1.1 EFVYKVNPNPYSKLPCHGRFNAYTPVRKNHATTTATKVFISGCVVIDMYPVCMAKTNSPNYKLNTMAELYLKQHKEDLSYKEIPVKFVSGAEGRAQVGKY 500
CgueCMV1.2 .................................................................................................... 500
CgueCMV1.1 CVQDAVLVKDLFNTINFHYEAGAIARLAKIPMRRVVFDGQQIRIYTSLLDECACRDFVLPNHKGAETSSDATTEVSYQGATVFEPEVGYYSDPVVVFDFA 600
CgueCMV1.2 .................................................................................................... 600
CgueCMV1.1 SLYPSIIMAHNLCYSTLVMPGGECPADDSQLFTVELENGVTYRFVKNTVRLSILSELLTKWVSQRRAVRETMRGCQDPVRRMLLDKEQLALKVTCNAFYG 700
CgueCMV1.2 .................................................................................................... 700
CgueCMV1.1 FTGVVNGMMPCLPIAASITRIGRDMLMRTSRFVNENFAEPCFLHNFFNREDYSGDPVEVKV 761
CgueCMV1.2 ............................................................. 761
CgueCMV1.1 MNLLQKLCVVCSKCNEYAMELECLKYCDPNVLAAESSPFKRNALAIAYLYRKIYPEVVRQNRTQTSLLTLYMEMILKALYEDTELLDRALKAYCRRPDRM 100
CgueCMV1.2 .................................................................................................... 100
CgueCMV1.1 EYYRTILRLDRCDRHHTVELTFTETVKFSVTLATLNDIERFLCKMNYVYAILAPETGLEVCSQLLQLLRRLCGVSPVACQEAYVEGTTCAQCYEELTIIP 200
CgueCMV1.2 .............................................................................V...................... 200
CgueCMV1.1 NQGRSLNKRLQGLLCNHIVVHRPSSQCDVNIQTVEQDLLDLTPRIPSLPGVLTALKNLFSSSSVYHSYIQEAEEALREYNLFTDIPARIYSLSDFTYWSR 300
CgueCMV1.2 .................................................................................................... 300
CgueCMV1.1 TSEVIVKRVGISIQQLNVYHHLCRVLMNSLSNHLYGEDVEDIFVVGEKLLSREERLFVGSVFAAPSRIIDLITSLSIQAFEGNPVFNKLHESNEMYTKIK 400
CgueCMV1.2 .................................................................................................... 400
CgueCMV1.1 CILEEIRRPVPDGAAGEAGAGSASRGQDRPNTSNN-SDAQNEDDDFLDWRDARTRMHNVTREVNMRKRAYLQKVSEVGYAKVIRCIKSQERLTSKLIDVN 499
CgueCMV1.2 .............................L.....N................................................................ 500
CgueCMV1.1 LIGTVCLDFISKLMNGFIYRTQYLDNPDLVDVAQLLSYDEHLYVVNNIIHKSLPAESLPLLGQQIYQLCNGPLFTHCTDRYPLSHNVDMAYACDNAGVLP 599
CgueCMV1.2 ..................................................................E................................. 600
CgueCMV1.1 HIKDDLVKCAEGTVYPSEWMVVKYQGFFNFSDCQDLNMLQKEMWKHVRELVLSVALYNETFGKQLTIACLRDELTTDRDLLLTYNKEWPLLLRHEGTLYK 699
CgueCMV1.2 .................................................................................................... 700
CgueCMV1.1 SKDLYLLLYRHLARPDEQRDVFRQPDSACVPAAAPRRVRAPRKRPRNSSLLLDLARDQDDQDLVPGCLR 768
CgueCMV1.2 ....................................................................C 769
1 2 3 4 5 6 7 8 9 10 11
DNA polymerase gene Glycoprotein B gene Major DNA-binding protein
ORF UL57 ORF UL56 ORF UL55 ORF UL54
kbp
UL56 (complete)
gB 1
gB 2
DPOL MDBP
Contiguous sequences
Glycoprotein B
(UL55; complete)
CgueCMV-1.1
CgueCMV-1.2
B
DNA polymerase
(UL54; partial)
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CgueCMV-2 might differ from CgueCMV-1 only in the gB
gene but not in the DPOL gene. This was indeed the case,
since we could connect the CgueCMV-2 gB sequence with
the CgueCMV-1 DPOL sequence by LD-PCR (Figures 1
and 5A).
Pairwise comparison of both CgueCMV nucleotide
sequences revealed a difference on the nucleotide level of
11% in the gB gene and only 2% in the DPOL gene. There-
fore, they were regarded as variants of the same viral spe-
cies and renamed CgueCMV-1.1 and CgueCMV-1.2. To
evaluate, (i) how broad the differences are between the
complete gB genes of both CgueCMV- 1.1 and CgueCMV-
1.2 and (ii) whether the conserved ORFs upstream of the
gB gene reveal extensive amino acid variations, we ampli-
fied with degenerate primers and sequenced a part of the
gene (ORF UL57) encoding for the MDBP (Figure 5A).
This sequence was connected with both the gB sequences
of CgueCMV-1.1 and CgueCMV-1.2 by LD-PCR (Figure
5A). For both viruses, a final sequence of about 8 kb was
determined, encoding a part of the ORF UL57 (MDBP),
the complete ORFs UL56 and UL55 (gB), and two thirds
of the ORF UL54 (DPOL) (Figure 6B). The nucleotide and
amino acid sequence differences of CgueCMV-1.1 and
CgueCMV-1.2 were 0.6% and 0.5% (UL56), 20% and 8%
(UL55) and 1% and 0.1% (UL54), respectively.
Phylogenetic analysis of the novel beta- and 
gammaherpesviruses
A phylogenetic tree was constructed with concatenated aa
sequences of gB and DPOL. It is the first comprehensive
tree of primate beta- and ammaherpesviruses based on gB
and DPOL sequences of more than 1000 aa. Nearly all
viruses branched with a probability of 70–100%.
Both the P. troglodytes rhadinoviruses (PtroRHV-1 and
PtroRHV-2) and the M. fascicularis rhadinoviruses (Mfas-
RHV-1 and MfasRHV-2) strongly confirmed the concept
of two distinct primate rhadinovirus lineages published
earlier [26]. While PtroRHV-1 and MfasRHV-1 appeared
as members of the RHV1 group (HHV8-like), PtroRHV-2
and MfasRHV-2 belonged to the RHV2 group of which the
M. mulatta rhadinovirus RRV is the best-characterized
member. The baboon lymphocryptoviruses PhamLCV-2
and PhamLCV-3 were closely related to each other and to
PhamLCV-1. They clustered in the group of Old World pri-
mate lymphocryptoviruses, of which EBV is the promi-
nent member. The colobus betaherpesviruses CgueCMV-
1.1 and 1.2 appeared as closely related members of the
genus Cytomegalovirus (Figure 6).
Discussion
This is the first report describing the differential amplifica-
tion of virus sequences by the aid of LNA-substituted oli-
gonucleotides. The LNA inhibited the amplification of
specific, perfectly matching HV DPOL sequences and ena-
bled the discovery of other, unknown HV DPOL
sequences. The versatility of this approach was demon-
strated by amplification of six novel primate herpesvirus
DPOL sequences from multi-infected samples. In these
experiments, LCV DPOL and RHV DPOL amplification
was inhibited by LNA addition. Furthermore, we success-
fully used CMV-specific LNAs to inhibit the amplification
of human CMV DPOL and gB genes and an LCV-specific
LNA to inhibit the amplification of ORF11 of LCV (Sandra
Prepens, Merlin Deckers, Katja Spieß and Bernhard Ehlers,
unpublished data). We concluded that the amplification
of every HV gene might be accessible to inhibition by
LNAs.
Phylogenetic analysis of the novel primate herpesviruses Figure 6
Phylogenetic analysis of the novel primate herpesvi-
ruses. A phylogenetic tree was constructed using the amino 
acid (aa) sequences encoded by the gB-DPOL segments of 
the novel primate herpesviruses and of known human and 
non-human primate herpesviruses, available in GenBank. A 
multiple alignment of concatenated 1100 aa was analysed 
with the neighbor-joining method. A midpoint-rooted phylo-
gram is shown. The branch length is proportional to evolu-
tionary distance (scale bar). Results of bootstrap analysis 
(100-fold) are indicated at the nodes of the tree, to the left of 
the first vertical divider. In addition, the alignment was ana-
lysed with Tree-Puzzle 5.0. Support values, estimated by the 
quartet puzzling (QP) tree search and expressing the QP reli-
ability in percent, are indicated at the nodes of the tree to 
the left of the vertical divider. Nodes with values below 70% 
in both analyses were depicted as pat of a multifurcation 
(black bar). Viruses, which are entirely novel or viruses for 
which additional sequence information was generated, are 
highlighted with black arrows. Herpesvirus genera and fami-
lies are indicated. Full names of known viruses and their 
nucleotide sequence accession numbers are listed in the 
Methods section.
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LNA-containing oligonucleotides exhibit varying effica-
cies and specificities with regards to their inhibitory
potential. Several factors may account for these differ-
ences: The primary sequence, the number of introduced
LNA bases and their position within the oligonucleotide,
and the secondary structures of the templates. We posi-
tioned most LNAs at the 3'- end of the second round
amplification product, as this is the region of the highest
sequence diversity among the amplification products of
the panherpes DPOL PCR. However, we accepted possible
interferences by secondary structures in some PCR tem-
plates. This may account for the fact that the LNA-EBV was
10 times more effective than LNA-PtroLCV1 and that 2
other LNAs had only partial inhibitory activity (data not
shown).
The positioning of the LNA-binding region to the compar-
atively variable 3'-end of the second round amplimer
allowed the amplification of HV DPOL sequences that dif-
fer only slightly from the LNA-targeted HV DPOL
sequence. In artificial template mixtures, closely related
HV sequences with only 2 to 3 mismatches in the LNA-
binding site could be selectively dissected by LNA addi-
tion. Furthermore, the novel PhamLCV-3 DPOL sequence
was found in an organ sample, which was also positive for
PhamLCV-2. Both sequences differ by only 3 bases in the
LNA-binding site. The LNA selectivity was likely sup-
ported by insertion of LNA bases exactly at mismatch
positions as illustrated by the higher specificity of the
LNA-GgorLCV1 (LNA substitutions at both mismatch
positions; Figure 2) compared to that of the LNA-
PtroLCV1 (no LNA substitution at the mismatch position;
Figure 2). Similar positional effects were reported using
LNA-substituted oligonucleotides as real-time PCR probes
[15,27]. Of course the selective placement of LNA bases at
mismatch positions cannot be carried out for unknown
sequences. Here, it is left to chance.
For inhibition of MfasLCV-1 and CgueLCV-1 amplifica-
tion, we used an LNA targeting the 5'-end of the amplifi-
cation product. This region is more conserved than the 3'-
end and does not allow for discrimination of closely
related sequences. However, non-LCV sequences (RHV or
CMV) were to be amplified in both cases, and therefore a
single, more conserved LNA was suitable in both experi-
ments.
The LNA technique was supplemented with amplification
of the gB gene, using different sets of genus-specific prim-
ers. With these, the amplification of 8 novel primate gB
sequences was achieved. Besides their general usefulness,
both detection approaches have specific constraints. Dif-
ferent sets of degenerate, genus-specific gB primers can in
principle amplify as many herpesvirus gB sequences from
a single sample as herpesvirus genera for a certain host
species exist. However, this can become laborious as
exemplified by primate herpesviruses. Two alpha-, two
beta- and two gammaherpesvirus genera are known
requiring at least 6 nested sets of gB primers. Furthermore,
viruses of quite similar sequence will exhibit an identity of
close to 100% in the binding regions of the consensus
primers. Therefore, they cannot be differentiated from the
same sample by gB PCR (without LNA addition).
In contrast to gB PCR, pan-herpes DPOL PCR in the pres-
ence of a sequence-specific LNA could differentiate
between very similar DPOL genes from the same genus.
An artificial mixture of four similar LCV templates could
be dissected by the addition of three LNAs, and two very
similar LCVs were found in a baboon spleen sample
(PhamLCV-2 without LNA; PhamLCV- 3 with LNA). Fur-
thermore, simultaneous addition of two LNAs resulted in
the exclusion of two viruses (PtroRHV-1 and PtroLCV-1)
and enabled the amplification of a third virus (PtroRHV-
2) from a single organ sample (Figure 4). Based on this
data we speculate that at least four herpesvirus species
might be discovered in a single sample. However, when
viruses like CgueCMV-1.1 and CgueCMV-1.2 are simulta-
neously present which do not differ in their DPOL but
only in their gB genes, differentiation would only be pos-
sible by (LNA-supplemented) amplification of the gB
gene.
For robust phylogenetic tree construction, the parallel tar-
geting of two conserved genes like DPOL and gB is supe-
rior to approaches used previously [11,7,28]. In those
reports, the initial short DPOL consensus sequence of
<200 bp was extended in upstream direction by about 300
bp with 2 rounds of semi-nested, semi-specific PCR. This
had resulted in a contiguous sequence of approximately
480 bp. Although this had improved the probability of
phylogenetic trees, the whole approach still yielded lim-
ited additional sequence information. Here we present
amplification of >3 kb sequences which encode for
approximately 350 aa of gB and 750 aa of DPOL. Such
data allows for the construction of phylogenetic trees of
significantly higher probability as exemplified by the tree
of primate beta- and gammaherpesviruses presented here
(Fig. 6).
The colobus monkey was infected with two different
strains of cytomegalovirus in many organs. Presently, we
do not know whether this double CMV infection contrib-
uted to the death of the animal. In humans, the simulta-
neous infection with different herpesviruses is not
uncommon and was linked to enhanced pathogenicity
and disease impact [29-32]. Moreover, mixed gB geno-
types of human CMV (HCMV) were found in immuno-
compromised patients [33], and specific HCMV gB
genotypes were associated with several human diseasesVirology Journal 2007, 4:84 http://www.virologyj.com/content/4/1/84
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[reviewed by [34]]. Therefore, technology for differentiat-
ing unknown viruses or unknown variants of recognized
viruses in clinical specimens is needed, and this require-
ment adds to the importance of the presented methodol-
ogy.
Very little information is available on the spectrum of
viruses in primates living in their natural habitats [35].
The LNA methodology, presented here, may become an
effective tool to comprehensively screen primates for
unknown pathogens, in particular those with zoonotic
potential.
Finally we predict that this novel technical approach is in
principle applicable to dissect mixed infections with
viruses from every viral family.
Abbreviations
CalHV-3 Callitrichine herpesvirus 3
CeHV-8 Cercopithecine herpesvirus 8
CeHV-15 Cercopithecine herpesvirus 15
CgueCMV-1.1 Colobus guereza cytomegalovirus 1.1
CgueCMV-1.2 Colobus guereza cytomegalovirus 1.2
CgueLCV-1 Colobus guereza lymphocryptovirus 1
EBV Epstein-Barr virus
GgorLCV-1 Gorilla gorilla lymphocryptovirus 1
HCMV Human cytomegalovirus
HHV-6A Human herpesvirus 6A
HHV-7 Human herpesvirus 7
HHV-8 Human herpesvirus 8
HVS Herpesvirus saimiri
MfasLCV-1 Macaca fascicularis lymphocryptovirus 1
MfasRHV-1 Macaca fascicularis rhadinovirus 1
MfasRHV-2 Macaca fascicularis rhadinovirus 2
PhamLCV-1 Papio hamadryas lymphocryptovirus 1
PhamLCV-2 Papio hamadryas lymphocryptovirus 2
PhamLCV-3 Papio hamadryas lymphocryptovirus 3
PLHV-1 Porcine lymphotropic herpesvirus 1
PtroCMV-1 Pan troglodytes cytomegalovirus 1
PtroLCV-1 Pan troglodytes lymphocryptovirus 1
PtroRHV-1 Pan troglodytes rhadinovirus 1
PtroRHV-2 Pan troglodytes rhadinovirus 2
RRV Rhesus monkey rhadinovirus
SaHV-2 Saimiriine herpesvirus 2
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